Bifogade filer
PDF
Kurs
+0,50%
Likviditet
0,01 MSEK
Kalender
| Tid* | ||
| 2025-05-16 | N/A | Årsstämma |
| 2025-02-28 | 08:00 | Bokslutskommuniké 2024 |
| 2024-11-20 | - | Kvartalsrapport 2024-Q3 |
| 2024-09-04 | - | Extra Bolagsstämma 2024 |
| 2024-08-28 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-28 | - | Kvartalsrapport 2024-Q1 |
| 2024-05-15 | - | X-dag ordinarie utdelning ISAB 0.00 SEK |
| 2024-05-14 | - | Årsstämma |
| 2024-02-28 | - | Bokslutskommuniké 2023 |
| 2023-11-22 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-29 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-31 | - | Kvartalsrapport 2023-Q1 |
| 2023-05-15 | - | X-dag ordinarie utdelning ISAB 0.00 SEK |
| 2023-05-12 | - | Årsstämma |
| 2023-02-28 | - | Bokslutskommuniké 2022 |
| 2022-11-22 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-29 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-08 | - | X-dag ordinarie utdelning ISAB 0.00 SEK |
| 2022-05-23 | - | Kvartalsrapport 2022-Q1 |
| 2022-05-06 | - | Årsstämma |
| 2022-02-28 | - | Bokslutskommuniké 2021 |
| 2021-11-24 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-26 | - | Kvartalsrapport 2021-Q2 |
| 2021-06-22 | - | Extra Bolagsstämma 2021 |
| 2021-06-09 | - | X-dag ordinarie utdelning ISAB 0.00 SEK |
| 2021-06-08 | - | Årsstämma |
| 2021-05-19 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-25 | - | Bokslutskommuniké 2020 |
| 2020-11-26 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-26 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-12 | - | Extra Bolagsstämma 2020 |
| 2020-05-13 | - | X-dag ordinarie utdelning ISAB 0.00 SEK |
| 2020-05-12 | - | Årsstämma |
| 2020-05-07 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-20 | - | Bokslutskommuniké 2019 |
| 2019-11-14 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-22 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-22 | - | Årsstämma |
| 2019-05-16 | - | Kvartalsrapport 2019-Q1 |
| 2019-05-10 | - | X-dag ordinarie utdelning ISAB 0.00 SEK |
| 2019-02-21 | - | Bokslutskommuniké 2018 |
| 2018-12-13 | - | Extra Bolagsstämma 2018 |
| 2018-11-15 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-22 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-24 | - | X-dag ordinarie utdelning ISAB 0.00 SEK |
| 2018-05-23 | - | Årsstämma |
| 2018-05-16 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-22 | - | Bokslutskommuniké 2017 |
| 2017-11-17 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-28 | - | Kvartalsrapport 2017-Q2 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Join Inhalation Sciences AB (ISAB) CEO Manoush Masarrat for a 2-minute company pitch and 20-minute analyst Q&A at the livestreamed Redeye Life Science Day, November 23, 2023.
ISAB has achieved robust growth for sales of its unique, high-precision platform technology and Inhalation Research Services (IRS), with a Q2 revenue increase of 36% compared to the same period last year, and a 500% growth in signed sales orders compared to the same period in the preceding year.
Manoush will be joining a host of other Nordic Life Science executives at the event.
Don't miss the opportunity to learn more about ISAB's recent achievements and developments - explore Life Science Day 2023 here: https://www.redeye.se/events/915984/redeye-life-science-day-2023?tab=attendingcompanies
Manoush Masarrat, CEO
E-mail: Manoush.masarrat@inhalation.se
Mobile: +46 (0)73 628 9153